Selected research
Market Structure
Global Pharma Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pharma Excipients market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pharma Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharma Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharma Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pharma Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pharma Excipients include J.M. Huber Corporation, Evonik, Eastman Chemical Company, DOW Chemical Company, Cargill, BASF, Archer Daniels Midland (ADM), AkzoNobel and ABITEC Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pharma Excipients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharma Excipients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharma Excipients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharma Excipients market size, projected growth trends, production technologies, key applications, and end-use industries.
Pharma Excipients Segment by Company
J.M. Huber Corporation
Evonik
Eastman Chemical Company
DOW Chemical Company
Cargill
BASF
Archer Daniels Midland (ADM)
AkzoNobel
ABITEC Corporation
Pharma Excipients Segment by Type
Alcohols
Polymers
Minerals
Sugar
Others
Pharma Excipients Segment by Application
Oral Solid Dosage Forms (OSDF)
Others
Pharma Excipients Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Excipients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pharma Excipients market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharma Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharma Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pharma Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Alcohols
- Polymers
- Minerals
- Sugar
- Others
Applications
- Oral Solid Dosage Forms (OSDF)
- Others
Companies covered
- J.M. Huber Corporation
- Evonik
- Eastman Chemical Company
- DOW Chemical Company
- Cargill
- BASF
- Archer Daniels Midland (ADM)
- AkzoNobel
- ABITEC Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharma Excipients Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharma Excipients Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pharma Excipients Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pharma Excipients Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pharma Excipients Market Dynamics
- 2.1 Pharma Excipients Industry Trends
- 2.2 Pharma Excipients Industry Drivers
- 2.3 Pharma Excipients Industry Opportunities and Challenges
- 2.4 Pharma Excipients Industry Restraints
3 Pharma Excipients Market by Manufacturers
- 3.1 Global Pharma Excipients Revenue by Manufacturers (2021-2026)
- 3.2 Global Pharma Excipients Sales by Manufacturers (2021-2026)
- 3.3 Global Pharma Excipients Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pharma Excipients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharma Excipients Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pharma Excipients Manufacturers, Product Type & Application
- 3.7 Global Pharma Excipients Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pharma Excipients Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pharma Excipients Players Market Share by Revenue in 2025
- 3.8.3 2025 Pharma Excipients Tier 1, Tier 2, and Tier 3
4 Pharma Excipients Market by Type
- 4.1 Pharma Excipients Type Introduction
- 4.1.1 Alcohols
- 4.1.2 Polymers
- 4.1.3 Minerals
- 4.1.4 Sugar
- 4.1.5 Others
- 4.2 Global Pharma Excipients Sales by Type
- 4.2.1 Global Pharma Excipients Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharma Excipients Sales by Type (2021-2032)
- 4.2.3 Global Pharma Excipients Sales Market Share by Type (2021-2032)
- 4.3 Global Pharma Excipients Revenue by Type
- 4.3.1 Global Pharma Excipients Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pharma Excipients Revenue by Type (2021-2032)
- 4.3.3 Global Pharma Excipients Revenue Market Share by Type (2021-2032)
5 Pharma Excipients Market by Application
- 5.1 Pharma Excipients Application Introduction
- 5.1.1 Oral Solid Dosage Forms (OSDF)
- 5.1.2 Others
- 5.2 Global Pharma Excipients Sales by Application
- 5.2.1 Global Pharma Excipients Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharma Excipients Sales by Application (2021-2032)
- 5.2.3 Global Pharma Excipients Sales Market Share by Application (2021-2032)
- 5.3 Global Pharma Excipients Revenue by Application
- 5.3.1 Global Pharma Excipients Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pharma Excipients Revenue by Application (2021-2032)
- 5.3.3 Global Pharma Excipients Revenue Market Share by Application (2021-2032)
6 Global Pharma Excipients Sales by Region
- 6.1 Global Pharma Excipients Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharma Excipients Sales by Region (2021-2032)
- 6.2.1 Global Pharma Excipients Sales by Region (2021-2026)
- 6.2.2 Global Pharma Excipients Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharma Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pharma Excipients Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pharma Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pharma Excipients Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pharma Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pharma Excipients Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pharma Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pharma Excipients Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pharma Excipients Revenue by Region
- 7.1 Global Pharma Excipients Revenue by Region
- 7.1.1 Global Pharma Excipients Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pharma Excipients Revenue by Region (2021-2026)
- 7.1.3 Global Pharma Excipients Revenue by Region (2027-2032)
- 7.1.4 Global Pharma Excipients Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pharma Excipients Revenue (2021-2032)
- 7.2.2 North America Pharma Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pharma Excipients Revenue (2021-2032)
- 7.3.2 Europe Pharma Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pharma Excipients Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pharma Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pharma Excipients Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pharma Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 J.M. Huber Corporation
- 8.1.1 J.M. Huber Corporation Company Information
- 8.1.2 J.M. Huber Corporation Business Overview
- 8.1.3 J.M. Huber Corporation Pharma Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 J.M. Huber Corporation Pharma Excipients Product Portfolio
- 8.1.5 J.M. Huber Corporation Recent Developments
- 8.2 Evonik
- 8.2.1 Evonik Company Information
- 8.2.2 Evonik Business Overview
- 8.2.3 Evonik Pharma Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Evonik Pharma Excipients Product Portfolio
- 8.2.5 Evonik Recent Developments
- 8.3 Eastman Chemical Company
- 8.3.1 Eastman Chemical Company Company Information
- 8.3.2 Eastman Chemical Company Business Overview
- 8.3.3 Eastman Chemical Company Pharma Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Eastman Chemical Company Pharma Excipients Product Portfolio
- 8.3.5 Eastman Chemical Company Recent Developments
- 8.4 DOW Chemical Company
- 8.4.1 DOW Chemical Company Company Information
- 8.4.2 DOW Chemical Company Business Overview
- 8.4.3 DOW Chemical Company Pharma Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 DOW Chemical Company Pharma Excipients Product Portfolio
- 8.4.5 DOW Chemical Company Recent Developments
- 8.5 Cargill
- 8.5.1 Cargill Company Information
- 8.5.2 Cargill Business Overview
- 8.5.3 Cargill Pharma Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Cargill Pharma Excipients Product Portfolio
- 8.5.5 Cargill Recent Developments
- 8.6 BASF
- 8.6.1 BASF Company Information
- 8.6.2 BASF Business Overview
- 8.6.3 BASF Pharma Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 BASF Pharma Excipients Product Portfolio
- 8.6.5 BASF Recent Developments
- 8.7 Archer Daniels Midland (ADM)
- 8.7.1 Archer Daniels Midland (ADM) Company Information
- 8.7.2 Archer Daniels Midland (ADM) Business Overview
- 8.7.3 Archer Daniels Midland (ADM) Pharma Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Archer Daniels Midland (ADM) Pharma Excipients Product Portfolio
- 8.7.5 Archer Daniels Midland (ADM) Recent Developments
- 8.8 AkzoNobel
- 8.8.1 AkzoNobel Company Information
- 8.8.2 AkzoNobel Business Overview
- 8.8.3 AkzoNobel Pharma Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 AkzoNobel Pharma Excipients Product Portfolio
- 8.8.5 AkzoNobel Recent Developments
- 8.9 ABITEC Corporation
- 8.9.1 ABITEC Corporation Company Information
- 8.9.2 ABITEC Corporation Business Overview
- 8.9.3 ABITEC Corporation Pharma Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 ABITEC Corporation Pharma Excipients Product Portfolio
- 8.9.5 ABITEC Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pharma Excipients Value Chain Analysis
- 9.1.1 Pharma Excipients Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pharma Excipients Production Mode & Process
- 9.2 Pharma Excipients Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharma Excipients Distributors
- 9.2.3 Pharma Excipients Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst